UY30135A1 - Quinolonas sustituidas iii - Google Patents

Quinolonas sustituidas iii

Info

Publication number
UY30135A1
UY30135A1 UY30135A UY30135A UY30135A1 UY 30135 A1 UY30135 A1 UY 30135A1 UY 30135 A UY30135 A UY 30135A UY 30135 A UY30135 A UY 30135A UY 30135 A1 UY30135 A1 UY 30135A1
Authority
UY
Uruguay
Prior art keywords
quinolones
iii
replaced
prophylaxis
drugs
Prior art date
Application number
UY30135A
Other languages
English (en)
Inventor
Rudolf Schohe-Loop
Kai Thede
Chantal Fuerstner
Brueckner David
Dr Holger Zimmermann
Dr Kerstin Henninger
Dieter Lang
Original Assignee
Aicuris Gmbh & Amp
Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicuris Gmbh & Amp, Co Kg filed Critical Aicuris Gmbh & Amp
Publication of UY30135A1 publication Critical patent/UY30135A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Quinolonas sustituedas y procesos para su preparacinn y su utilizacinn para la produccinn de medicamentos para el tratamiento y/o profilaxis de enfermedades, especialmente para su utilización como agentes antivirales, particularmente contra los citomegalovirus.
UY30135A 2006-02-09 2007-02-07 Quinolonas sustituidas iii UY30135A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006005861A DE102006005861A1 (de) 2006-02-09 2006-02-09 Substituierte Chinolone III

Publications (1)

Publication Number Publication Date
UY30135A1 true UY30135A1 (es) 2007-09-28

Family

ID=38283107

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30135A UY30135A1 (es) 2006-02-09 2007-02-07 Quinolonas sustituidas iii

Country Status (28)

Country Link
US (1) US7977349B2 (es)
EP (1) EP1994020B1 (es)
JP (1) JP5198291B2 (es)
KR (1) KR101400568B1 (es)
CN (1) CN101379055B (es)
AR (1) AR059417A1 (es)
AT (1) ATE513826T1 (es)
AU (1) AU2007214006B2 (es)
BR (1) BRPI0706988A2 (es)
CA (1) CA2637204C (es)
CY (1) CY1111805T1 (es)
DE (1) DE102006005861A1 (es)
DK (1) DK1994020T3 (es)
DO (1) DOP2007000027A (es)
ES (1) ES2366970T3 (es)
HK (1) HK1125372A1 (es)
IL (1) IL192662A (es)
MY (1) MY151590A (es)
PE (1) PE20080113A1 (es)
PL (1) PL1994020T3 (es)
PT (1) PT1994020E (es)
RU (1) RU2433125C2 (es)
SI (1) SI1994020T1 (es)
TW (1) TWI382980B (es)
UA (1) UA94934C2 (es)
UY (1) UY30135A1 (es)
WO (1) WO2007090579A2 (es)
ZA (1) ZA200806355B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR059339A1 (es) * 2006-02-09 2008-03-26 Chugai Pharmaceutical Co Ltd Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene
TW200811153A (en) 2006-06-23 2008-03-01 Japan Tobacco Inc 6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor
DE102011101446A1 (de) * 2011-05-10 2012-11-15 Aicuris Gmbh & Co. Kg Herstellung von "Dense Bodies" (DB)
WO2018110669A1 (en) 2016-12-15 2018-06-21 Ono Pharmaceutical Co., Ltd. Activator of trek (twik related k+ channels) channels

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB932487A (en) 1960-07-25 1963-07-31 D G Searle & Co Piperidine derivatives
DE3420743A1 (de) 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
FI871419A (fi) 1986-03-31 1987-10-01 Sankyo Co Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning.
DE3702393A1 (de) * 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
FI95130C (fi) 1988-07-20 1995-12-27 Sankyo Co Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
US4959363A (en) 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
DE4303657A1 (de) 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate
FR2713116B1 (fr) 1993-11-30 1996-01-12 Techmetal Promotion Dispositif d'alimentation pour le dépôt par simple gravité d'un matériau granuleux sur la surface d'un métal liquide coulé en continu.
KR960004339A (ko) 1994-07-02 1996-02-23 임성기 신규한 퀴놀린계 화합물 및 그 의 제조방법
EP0841929B1 (en) 1995-08-02 2003-05-07 Darwin Discovery Limited Quinolones and their therapeutic use
ATE258437T1 (de) 1995-08-02 2004-02-15 Darwin Discovery Ltd Chinolone und deren therapeutische verwendung
US6248739B1 (en) * 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
DE19937024A1 (de) * 1999-08-05 2001-02-08 Bayer Ag Verwendung von Acylsulfonamido substituierten Polymethin-Farbstoffen als Fluoreszenz-Farbstoffe und/oder Marker
US6525049B2 (en) * 2000-07-05 2003-02-25 Pharmacia & Upjohn Company Pyrroloquinolones as antiviral agents
CA2417799A1 (en) 2000-08-01 2002-02-07 Wockhardt Limited Inhibitors of cellular efflux pumps of microbes
GB0023918D0 (en) 2000-09-29 2000-11-15 King S College London Antiparasitic compounds
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
WO2003050107A1 (en) 2001-12-13 2003-06-19 Wockhardt Limited New generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
AU2004229489B2 (en) 2003-04-07 2010-03-04 Cylene Pharmaceuticals, Inc. Substituted quinobenzoxazine analogs
WO2005049602A1 (en) * 2003-11-18 2005-06-02 Warner-Lambert Company Llc Quinolone antibacterial agents
DE102004035203A1 (de) 2004-07-21 2006-02-16 Bayer Healthcare Ag Substituierte Chinolone
DE102005030524A1 (de) * 2005-06-30 2007-01-18 Aicuris Gmbh & Co. Kg Substituierte Chinolone II

Also Published As

Publication number Publication date
EP1994020B1 (de) 2011-06-22
HK1125372A1 (en) 2009-08-07
TWI382980B (zh) 2013-01-21
WO2007090579A3 (de) 2007-11-15
ES2366970T3 (es) 2011-10-27
CA2637204C (en) 2013-04-16
WO2007090579A2 (de) 2007-08-16
PL1994020T3 (pl) 2011-10-31
AU2007214006B2 (en) 2011-11-03
PE20080113A1 (es) 2008-04-18
CN101379055A (zh) 2009-03-04
CA2637204A1 (en) 2007-08-16
JP5198291B2 (ja) 2013-05-15
ATE513826T1 (de) 2011-07-15
MY151590A (en) 2014-06-13
UA94934C2 (uk) 2011-06-25
TW200808757A (en) 2008-02-16
RU2433125C2 (ru) 2011-11-10
CN101379055B (zh) 2012-12-05
JP2009525999A (ja) 2009-07-16
AR059417A1 (es) 2008-04-09
ZA200806355B (en) 2010-02-24
DE102006005861A1 (de) 2007-08-23
EP1994020A2 (de) 2008-11-26
KR101400568B1 (ko) 2014-05-26
AU2007214006A1 (en) 2007-08-16
US7977349B2 (en) 2011-07-12
DK1994020T3 (da) 2011-09-19
KR20080100248A (ko) 2008-11-14
CY1111805T1 (el) 2015-10-07
IL192662A0 (en) 2009-08-03
SI1994020T1 (sl) 2011-10-28
IL192662A (en) 2013-04-30
BRPI0706988A2 (pt) 2011-04-19
DOP2007000027A (es) 2007-10-31
US20090181996A1 (en) 2009-07-16
PT1994020E (pt) 2011-09-02
RU2008136079A (ru) 2010-03-20

Similar Documents

Publication Publication Date Title
UY30178A1 (es) Aril sulfonamidas sustituidas
CU23874B1 (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
UY30846A1 (es) Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
HN2004000146A (es) Dihidroquinazolinas sustituidas
UY34657A (es) ?derivados macrocíclicos para el tratamiento de enfermedades?.
UY31228A1 (es) Ariloxazoles sustituidos y su uso
CR11684A (es) Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa
UY32882A (es) (heteroarilmetil) tiohidantoínas sustituidas
CR20110210A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales
UY31133A1 (es) "oxazolidinonas sustituidas y su uso"
ATE380188T1 (de) Substituierte chinolone
ECSP11011483A (es) Piperidinas sustituidas
HN2006007774A (es) Imidazoles sustituidos con heterociclilamida
UY29189A1 (es) Nonadepsipeptidos acilados ii
UY31717A1 (es) (pirazolilcarbonil) imidazolidinonas sustituidas y su uso
CU20110214A7 (es) Piperidinas sustituidas
UY30135A1 (es) Quinolonas sustituidas iii
UY35610A (es) Derivados de prodroga de triazolpiridinas sustituidas
ATE553088T1 (de) Substituierte chinolone ii
CU23725B7 (es) Quinolonas sustituidas iii
CU20070201A7 (es) Imidazoles sustituidos con heterociclilamida
CU23488B7 (es) Dihidroquinazolinas sustituidas con propiedades antivirales
DOP2004000895A (es) Dihidroquinazolinas sustituidas con propiedades antivirales
DOP2005000223A (es) Nonadepsipeptidos acilados ii

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20210204